{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T13:23:22Z","timestamp":1740144202903,"version":"3.37.3"},"reference-count":14,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"47","license":[{"start":{"date-parts":[[2020,11,20]],"date-time":"2020-11-20T00:00:00Z","timestamp":1605830400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Tuberculosis (TB) is the leading cause of health complications and death among human with immunodeficiency virus (HIV) infection. When TB develops during pregnancy or the early postpartum period, it is associated with negative maternal, pregnancy, and fetus and infant outcome, including premature birth, low birth weight, and congenital or neonatal TB infection or disease. The objective of this systematic review is to investigate the effective and safe of isoniazid for preventing TB for HIV-infected pregnant women in counties with high prevalence of TB.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>Pubmed, Embase, and Cochrane library will be searched to include randomized control trials which compared isoniazid preventive therapy with placebo for preventing TB in HIV-infected pregnant and postpartum women. RevMan version 5.3 will be used to perform all calculations related to the meta-analysis. Dichotomous data will be calculated in terms of a fixed or random effect model and expressed by the relative risk (RR) with 95% confidence interval (CI). The Cochrane collaboration's tool in the following aspects was used to assess the risk of bias (ROB) in included studies. The inconsistency index (I2) and Chi-squared will be applied for heterogeneity detection between clinical trials. A value of <jats:italic toggle=\"yes\">P\u200a<\/jats:italic>&lt;\u200a0.05 will be considered statistically significant.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>The main outcomes of pooled evidence synthesis will be presented including the incidence of TB and adverse events.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>This study will provide the evidence of whether isoniazid is an effective and safe intervention for preventing TB for HIV-infected pregnant women.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Registration number:<\/jats:title>\n            <jats:p>INPLASY202070011<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000023089","type":"journal-article","created":{"date-parts":[[2020,11,18]],"date-time":"2020-11-18T08:49:12Z","timestamp":1605689352000},"page":"e23089","source":"Crossref","is-referenced-by-count":0,"title":["Isoniazid preventive therapy in HIV-infected pregnant and postpartum women in high prevalence of tuberculosis countries"],"prefix":"10.1097","volume":"99","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5542-9950","authenticated-orcid":false,"given":"Xiaozhuan","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaojuan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingmei","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoling","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Bai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2020,11,20]]},"reference":[{"key":"R1-20230916","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1056\/NEJMoa1813060","article-title":"Isoniazid preventive therapy in HIV-infected pregnant and postpartum women","volume":"381","author":"Gupta","year":"2019","journal-title":"N Engl J Med"},{"key":"R2-20230916","doi-asserted-by":"crossref","first-page":"e62211","DOI":"10.1371\/journal.pone.0062211","article-title":"High prevalence of pulmonary tuberculosis but low sensitivity of symptom screening among HIV-infected pregnant women in South Africa","volume":"8","author":"Hoffmann","year":"2013","journal-title":"PLoS One"},{"key":"R3-20230916","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/j.1471-0528.2010.02504.x","article-title":"Increased risk of low birthweight and small for gestational age infants among women with tuberculosis","volume":"117","author":"Lin","year":"2010","journal-title":"BJOG"},{"key":"R4-20230916","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1097\/QAI.0b013e3181900201","article-title":"Intensified case finding for tuberculosis in prevention of mother-to-child transmission programs: a simple and potentially vital addition for maternal and child health","volume":"50","author":"Deluca","year":"2009","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R5-20230916","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1097\/00002030-200109280-00016","article-title":"Maternal mortality associated with tuberculosis-HIV-1 co-infection in Durban, South Africa","volume":"15","author":"Khan","year":"2001","journal-title":"AIDS"},{"key":"R6-20230916","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S0188-4409(00)00266-6","article-title":"Neonatal outcome of children born to women with tuberculosis","volume":"32","author":"Figueroa-Dami\u00e1n","year":"2001","journal-title":"Arch Med Res"},{"key":"R7-20230916","first-page":"675","article-title":"A study of maternal mortality at the University Teaching Hospital, Lusaka, Zambia: the emergence of tuberculosis as a major non-obstetric cause of maternal death","volume":"3","author":"Ahmed","year":"1999","journal-title":"Int J Tuberc Lung Dis"},{"key":"R9-20230916","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0020-7292(94)90064-7","article-title":"Perinatal outcome in pregnancies complicated by pulmonary tuberculosis","volume":"44","author":"Jana","year":"1994","journal-title":"Int J Gynaecol Obstet"},{"key":"R11-20230916","first-page":"151","article-title":"Isoniazid hepatitis among pregnant and postpartum Hispanic patients","volume":"104","author":"Franks","year":"1989","journal-title":"Public Health Rep"},{"issue":"(2 pt 1)","key":"R12-20230916","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1164\/ajrccm\/145.2_Pt_1.494","article-title":"Isoniazid-associated hepatitis deaths: a review of available information","volume":"145","author":"Snider","year":"1992","journal-title":"Am Rev Respir Dis"},{"key":"R14-20230916","doi-asserted-by":"crossref","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"key":"R15-20230916","doi-asserted-by":"crossref","first-page":"989","DOI":"10.2165\/00003088-200544100-00001","article-title":"Pregnancy-induced changes in pharmacokinetics: a mechanistic-based approach","volume":"44","author":"Anderson","year":"2005","journal-title":"Clin Pharmacokinet"},{"key":"R16-20230916","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1053\/sper.2001.24565","article-title":"Physiologic changes in pregnancy and their effect on drug disposition","volume":"25","author":"Frederiksen","year":"2001","journal-title":"Semin Perinatol"},{"key":"R17-20230916","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1056\/NEJMra1213566","article-title":"Pregnancy and infection","volume":"370","author":"Kourtis","year":"2014","journal-title":"N Engl J Med"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000023089","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,16]],"date-time":"2023-09-16T02:22:17Z","timestamp":1694830937000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000023089"}},"subtitle":["A protocol for systematic review"],"short-title":[],"issued":{"date-parts":[[2020,11,20]]},"references-count":14,"journal-issue":{"issue":"47","published-online":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000023089","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"type":"print","value":"0025-7974"},{"type":"electronic","value":"1536-5964"}],"subject":[],"published":{"date-parts":[[2020,11,20]]}}}